Literature DB >> 9353066

The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes.

T L Benfield1, B Lundgren, S J Levine, G Kronborg, J H Shelhamer, J D Lundgren.   

Abstract

Recent studies suggest that interleukin-8 (IL-8) and tumor necrosis factor alpha (TNF-alpha) may play a central role in host defense and pathogenesis during Pneumocystis carinii pneumonia. In order to investigate whether the major surface antigen (MSG) of human P. carinii is capable of eliciting the release of IL-8 and TNF-alpha, human monocytes were cultured in the presence of purified MSG. MSG-stimulated cells released significant amounts of IL-8 within 4 h, and at 20 h, cells stimulated with MSG released 45.5 +/- 9.3 ng of IL-8/ml versus 3.7 +/- 1.1 ng/ml for control cultures (P = 0.01). In a similar fashion, MSG elicited release of TNF-alpha. Initial increases were also seen at 4 h, and at 20 h, TNF-alpha levels reached 6.4 +/- 1.1 ng/ml, compared to 0.08 +/- 0.01 ng/ml for control cultures (P < 0.01). A concentration-dependent increase in IL-8 and TNF-alpha secretion was observed at 20 h with 0.2 to 5 microg of MSG/ml (P < 0.01). Secretion of IL-8 and TNF-alpha from MSG-stimulated monocytes at 20 h was inhibited by 60 and 86%, respectively, after coincubation with soluble yeast mannan (P = 0.01). With an RNase protection assay, increases in steady-state mRNA levels for IL-8 and TNF-alpha were detectable at 4 h. These data show that recognition of MSG by monocytes involves a mannose-mediated mechanism and results in the release of the proinflammatory cytokines IL-8 and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353066      PMCID: PMC175687          DOI: 10.1128/iai.65.11.4790-4794.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Prevention and treatment of pneumocystis pneumonia.

Authors:  H Masur
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

2.  Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha.

Authors:  C Agostini; R Zambello; L Trentin; S Garbisa; P F Di Celle; P Bulian; M Onisto; V Poletti; L Spiga; E Raise
Journal:  Am Rev Respir Dis       Date:  1991-07

Review 3.  Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]).

Authors:  E J Leonard; T Yoshimura
Journal:  Am J Respir Cell Mol Biol       Date:  1990-06       Impact factor: 6.914

4.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor.

Authors:  R A Ezekowitz; D J Williams; H Koziel; M Y Armstrong; A Warner; F F Richards; R M Rose
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

5.  Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia.

Authors:  J K Kolls; J M Beck; S Nelson; W R Summer; J Shellito
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

6.  Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism.

Authors:  O A Hoffman; J E Standing; A H Limper
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

7.  Purification and characterization of a major human Pneumocystis carinii surface antigen.

Authors:  B Lundgren; G Y Lipschik; J A Kovacs
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages.

Authors:  D Israël-Biet; J Cadranel; K Beldjord; J M Andrieu; A Jeffrey; P Even
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

9.  Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction.

Authors:  F Gigliotti; P J Haidaris; C G Haidaris; T W Wright; K R Van der Meid
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

10.  Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein.

Authors:  S T Pottratz; J Paulsrud; J S Smith; W J Martin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more
  6 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.

Authors:  Sanbao Ruan; Yang Cai; Alistair J Ramsay; David A Welsh; Karen Norris; Judd E Shellito
Journal:  Vaccine       Date:  2016-12-21       Impact factor: 3.641

3.  Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.

Authors:  T W Wright; C J Johnston; A G Harmsen; J N Finkelstein
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 4.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms.

Authors:  J F Downing; D L Kachel; R Pasula; W J Martin
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia.

Authors:  D Israël-Biet; H Esvant; A M Laval; J Cadranel
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.